MedPath

TEVA-PROPOFOL

TEVA-PROPOFOL

Dormant
DIN Number

02437961

Drug Class

Human

Market Date

Nov 20, 2015

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02437961
AIG Number0121833001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N01AX10 PROPOFOL
Product Specifications
Dosage FormEmulsion
Route of AdministrationIntravenous
AHFS Classification28:04.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

PROPOFOLActive
Strength: 10 MG / ML
Monograph: PROPOFOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.